...
首页> 外文期刊>American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons >Addendum to Jeng L‐B, et al. Efficacy and safety of everolimus with reduced tacrolimus in living‐donor liver transplant recipients: 12‐month results of a randomized multicenter study. Am J Transplant. 2018;18:1435–1446
【24h】

Addendum to Jeng L‐B, et al. Efficacy and safety of everolimus with reduced tacrolimus in living‐donor liver transplant recipients: 12‐month results of a randomized multicenter study. Am J Transplant. 2018;18:1435–1446

机译:Addendum to Jeng L‐B, et al. Efficacy and safety of everolimus with reduced tacrolimus in living‐donor liver transplant recipients: 12‐month results of a randomized multicenter study. Am J Transplant. 2018;18:1435–1446

获取原文
获取原文并翻译 | 示例
           

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号